 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

- MSS CRC case examples reinforce optimal dosing regimen in ongoing phase 2 dose expansion, with a confirmed partial response at ADG126 10 mg/kg every three weeks plus pembrolizumab - Integrated...

Adagene Presents Data Demonstrating the Best-in-Class Therapeutic Index for Masked Anti-CTLA-4 SAFEbody  ADG126 at SITC 2023

HC Wainwright reissued their buy rating on shares of Adagene (NASDAQ:ADAG  Free Report) in a report released on Wednesday morning, Benzinga reports. HC Wainwright currently has a $5.00 price...

Adagene (NASDAQ:ADAG) Stock Rating Reaffirmed by HC Wainwright

Adagene Inc. (NASDAQ:ADAG  Get Free Report) was the target of a large decrease in short interest during the month of September. As of September 15th, there was short interest totalling 25,100...

Short Interest in Adagene Inc. (NASDAQ:ADAG) Decreases By 14.0%

Adagene s CEO, Dr. Peter Luo, participating in SITC webinar on September 22 focused on essential role of Treg depletion for anti-CTLA-4 therapies SAN DIEGO and SUZHOU, China, Sept. 07, 2023...

Adagene to Present at Investor and Scientific Conferences in September

Adagene Inc. (NASDAQ:ADAG Get Free Report) was the recipient of a significant drop in short interest in July. As of July 15th, there was short interest totalling 18,200 shares, a drop of 34.1% from the June 30th total of 27,600 shares. Based on an average trading volume of 24,800 shares, the days-to...

Short Interest in Adagene Inc. (NASDAQ:ADAG) Drops By 34.1%

Adagene Inc. (NASDAQ:ADAG  Get Free Report) saw a significant growth in short interest in the month of June. As of June 30th, there was short interest totalling 27,600 shares, a growth of 200.0% from the June 15th total of 9,200 shares. Based on an average trading volume of 24,100 shares, the...

Adagene Inc. (NASDAQ:ADAG) Short Interest Up 200.0% in June

Adagene Inc. (NASDAQ:ADAG Free Report) was the recipient of a large decline in short interest during the month of June. As of June 15th, there was short interest totalling 9,200 shares, a decline of 48.9% from the May 31st total of 18,000 shares. Currently, 0.0% of the companys shares are sold short...

Adagene Inc. (NASDAQ:ADAG) Sees Significant Drop in Short Interest

Adagene Inc. (NASDAQ:ADAG  Free Report) saw a significant decline in short interest in June. As of June 15th, there was short interest totalling 9,200 shares, a decline of 48.9% from the May 31st total of 18,000 shares. Currently, 0.0% of the companys stock are sold short. Based on an ...

Adagene Inc. (NASDAQ:ADAG) Sees Significant Decline in Short Interest

Adagene Inc. (NASDAQ:ADAG Get Rating) was the target of a large decrease in short interest in May. As of May 31st, there was short interest totalling 18,000 shares, a decrease of 8.2% from the May 15th total of 19,600 shares. Currently, 0.0% of the shares of the stock are sold short. Based on an...

Adagene Inc. (NASDAQ:ADAG  Get Rating) saw a large drop in short interest in May. As of May 31st, there was short interest totalling 18,000 shares, a drop of 8.2% from the May 15th total of 19,600 shares. Based on an average trading volume of 11,000 shares, the days-to-cover ratio is ...

Adagene, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel antibody-based cancer immunotherapies. Its dynamic precision library platform is composed of the following proprietary technologies: NEObody, SAFEbody, and POWERbody. The company was founded by Ge Li and Pei Zhi Luo on February 25, 2011 and is headquartered in Suzhou, China.

Watchers	123
52-Wk Low	$1.01
52-Wk High	$2.10

Market Cap	$75.69M
Volume (M)	14,964.00
52-Wk High	$2.10
52-Wk Low	$1.01

ADAG Adagene Inc - ADR

About

Feed

News

Sentiment

Fundamentals